Filing Details
- Accession Number:
- 0001161697-19-000538
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-06 16:52:22
- Reporting Period:
- 2019-12-04
- Accepted Time:
- 2019-12-06 16:52:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369568 | Catalyst Pharmaceuticals Inc. | CPRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1279473 | Gary Ingenito | 355 Alhambra Circle, Suite 1250 Coral Gables FL 33134 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2019-12-04 | 150,000 | $2.53 | 150,000 | No | 4 | M | Direct | |
| Common Stock, Par Value $0.001 Per Share | Disposition | 2019-12-05 | 150,000 | $4.82 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options to purchase common stock | Acquisiton | 2019-12-04 | 150,000 | $0.00 | 150,000 | $2.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 886,000 | 2022-12-30 | No | 4 | M | Direct |
Footnotes
- Dr. Ingenito has advised the Company that this sale of shares was to complete the raising of funds required for the purchase of a home by a family member and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies and practices. Dr. Ingenito remains an officer of the Company.
- The option was granted on December 30, 2015 and previously vested in two equal annual installments.
Billionaire Hedge Funds
